Hypoxia of PC-3 prostate cancer cells enhances migration and vasculogenesis in vitro of bone marrow-derived endothelial progenitor cells by secretion of cytokines

Oncology Reports

Volumn 29, Issue 6, 2013, Pages 2369-2377

  Huang, Shuai ^a   Peng, Longyun ^a   Tang, Yubo ^a   Zhang, Longjuan ^a   Guo, Wei ^a   Zou, Xuenong ^a   Peng, Xinsheng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bone marrow derived endothelial progenitor cell; Cytokine; Hypoxia; Migration; Prostate cancer cell; Vasculogenesis

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CD31 ANTIGEN; CILIARY NEUROTROPHIC FACTOR; CXCL16 CHEMOKINE; CYTOKINE; EOTAXIN; EOTAXIN 2; EOTAXIN 3; FAS LIGAND; FIBROBLAST GROWTH FACTOR 6; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 19; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 5 RECEPTOR; INTERLEUKIN 6 RECEPTOR; KERATINOCYTE GROWTH FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; RANTES; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA2; UNINDEXED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CANCER CELL; CANCER CELL CULTURE; CELL ACTIVITY; CELL FUNCTION; CELL HYPOXIA; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PC 3 CELL LINE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, DIFFERENTIATION; BONE MARROW CELLS; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; CYTOKINES; ENDOTHELIAL CELLS; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; STEM CELLS; UP-REGULATION;

EID: 84876212413     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2363     Document Type: Article

References (41)

1. Roodman GD: Mechanisms of bone metastasis. N Engl J Med 350: 1655-1664, 2004.
2. Mundy GR: Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584-593, 2002.
3. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
4. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K and Mittal V: Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319: 195-198, 2008.
5. Liao D and Johnson RS: Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26: 281-290, 2007. (Pubitemid 47101669)
6. Lee SL, Rouhi P, Dahl Jensen L, et al: Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model. Proc Natl Acad Sci USA 106: 19485-19490, 2009.
7. Senger DR and Davis GE: Angiogenesis. Cold Spring Harb Perspect Biol 3: a005090, 2011.
8. Asahara T and Kawamoto A: Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 287: C572-C579, 2004. (Pubitemid 39095841)
9. Wickersheim A, Kerber M, de Miguel LS, Plate KH and Machein MR: Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors. Int J Cancer 125: 1771-1777, 2009.
10. De Palma M and Naldini L: Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis. Biochim Biophys Acta 1766: 159-166, 2006. (Pubitemid 44175637)
11. Spring H, Schüler T, Arnold B, Hämmerling GJ and Ganss R: Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci USA 102: 18111-18116, 2005. (Pubitemid 41798510)
12. Nolan DJ, Ciarrocchi A, Mellick AS, et al: Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 21: 1546-1558, 2007. (Pubitemid 46955726)
13. Gao D, Nolan D, McDonnell K, Vahdat L, Benezra R, Altorki N and Mittal V: Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta 1796: 33-40, 2009.
14. + progenitors able to promote cancer progression. Cancer Res 72: 325-334, 2012.
15. Döme B, Hendrix MJ, Paku S, Tóvári J and Tímár J: Alternative vascularization mechanisms in cancer: pathology and therapeutic implications. Am J Pathol 170: 1-15, 2007.
16. Strohmeyer D, Rössing C, Strauss F, Bauerfeind A, Kaufmann O and Loening S: Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer. Prostate 42: 26-33, 2000. (Pubitemid 30004872)
17. Revelos K, Petraki C, Scorilas A, et al: Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer. Anticancer Res 27: 3651-3660, 2007. (Pubitemid 47607515)
18. Lissbrant IF, Stattin P, Damber JE and Bergh A: Vascular density is a predictor of cancer-specific survival in prostatic carcinoma. Prostate 33: 38-45, 1997. (Pubitemid 27381593)
19. Asahara T, Takahashi T, Masuda H, et al: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972, 1999. (Pubitemid 29335849)
20. Orimo A, Gupta PB, Sgroi DC, et al: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005. (Pubitemid 40692295)
21. Powell TM, Paul JD, Hill JM, et al: Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 25: 296-301, 2005. (Pubitemid 40189148)
22. Takahashi T, Kalka C, Masuda H, et al: Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438, 1999. (Pubitemid 29180584)
23. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P and Young PP: VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 20: 1495-1497, 2006.
24. Maeng YS, Choi HJ, Kwon JY, et al: Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLCβ2 axis. Blood 113: 233-243, 2009.
25. Liu ZJ, Tian R, Li Y, An W, Zhuge Y, Livingstone AS and Velazquez OC: Inhibition of tumor angiogenesis and melanoma growth by targeting vascular E-selectin. Ann Surg 254: 450-457, 2011.
26. Gill KA and Brindle NP: Angiopoietin-2 stimulates migration of endothelial progenitors and their interaction with endothelium. Biochem Biophys Res Commun 336: 392-396, 2005. (Pubitemid 41268664)
27. Shiozawa Y, Pedersen EA, Havens AM, et al: Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest 121: 1298-1312, 2011.
28. Chow DC, Wenning LA, Miller WM and Papoutsakis ET: Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys J 81: 685-696, 2001. (Pubitemid 32721444)
29. Harrison JS, Rameshwar P, Chang V and Bandari P: Oxygen saturation in the bone marrow of healthy volunteers. Blood 99: 394, 2002.
30. Tang Y, Huang B, Sun L, Peng X, Chen X and Zou X: Ginkgolide B promotes proliferation and functional activities of bone marrow-derived endothelial progenitor cells: involvement of Akt/eNOS and MAPK/p38 signaling pathways. Eur Cell Mater 21: 459-469, 2011.
31. Asahara T, Masuda H, Takahashi T, et al: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999. (Pubitemid 29377293)
32. Lyden D, Hattori K, Dias S, et al: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7: 1194-1201, 2001. (Pubitemid 33063774)
33. Langer HF, May AE, Vestweber D, De Boer HC, Hatzopoulos AK and Gawaz M: Platelet-induced differentiation of endothelial progenitor cells. Semin Thromb Hemost 33: 136-143, 2007. (Pubitemid 46427755)
34. Nassiri F, Cusimano MD, Scheithauer BW, et al: Rotondo F Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res 31: 2283-2290, 2011.
35. Fan Y, Ye J, Shen F, et al: Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab 28: 90-98, 2008.
36. Silverman MD, Haas CS, Rad AM, Arbab AS and Koch AE: The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium. Arthritis Rheum 56: 1817-1826, 2007. (Pubitemid 47110381)
37. Wu Y, Ip JE, Huang J, et al: Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res 99: 315-322, 2006. (Pubitemid 44174940)
38. Humpert PM, Djuric Z, Zeuge U, et al: Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling. Mol Med 14: 301-308, 2008. (Pubitemid 351785703)
39. Garcia-Barros M, Paris F, Cordon-Cardo C, et al: Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300: 1155-1159, 2003. (Pubitemid 36583102)
40. Wang QR, Wang F, Zhu WB, Lei J, Huang YH, Wang BH and Yan Q: GM-CSF accelerates proliferation of endothelial progenitor cells from murine bone marrow mononuclear cells in vitro. Cytokine 45: 174-178, 2009.
41. Kim KL, Shin IS, Kim JM, et al: Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells. Cardiovasc Res 72: 394-402, 2006. (Pubitemid 44665844)